EHF
Basic information
Region (hg38): 11:34621093-34663288
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EHF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 1 |
Variants in EHF
This is a list of pathogenic ClinVar variants found in the EHF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-34632633-T-C | not specified | Uncertain significance (Jul 27, 2024) | ||
11-34642687-C-G | not specified | Uncertain significance (Dec 05, 2022) | ||
11-34642692-C-T | not specified | Uncertain significance (Nov 12, 2021) | ||
11-34646445-G-C | not specified | Uncertain significance (Apr 12, 2022) | ||
11-34646485-G-C | not specified | Uncertain significance (May 25, 2022) | ||
11-34646522-C-A | not specified | Uncertain significance (Oct 24, 2024) | ||
11-34646538-A-G | not specified | Uncertain significance (Sep 30, 2021) | ||
11-34646594-C-A | not specified | Uncertain significance (Nov 17, 2023) | ||
11-34646624-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
11-34646625-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
11-34649028-G-A | not specified | Uncertain significance (Mar 20, 2023) | ||
11-34649059-C-T | Benign (Apr 24, 2018) | |||
11-34651570-C-A | not specified | Likely benign (Jun 07, 2024) | ||
11-34651575-A-G | not specified | Uncertain significance (Feb 12, 2024) | ||
11-34651577-T-A | not specified | Uncertain significance (Oct 21, 2024) | ||
11-34651764-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
11-34651802-G-T | not specified | Uncertain significance (Nov 28, 2024) | ||
11-34656938-A-T | not specified | Uncertain significance (Aug 17, 2022) | ||
11-34656941-C-A | not specified | Likely benign (Dec 28, 2022) | ||
11-34656950-A-C | not specified | Uncertain significance (Oct 05, 2021) | ||
11-34656955-C-A | not specified | Uncertain significance (Mar 06, 2023) | ||
11-34658622-T-A | not specified | Uncertain significance (Jul 16, 2024) | ||
11-34658631-G-A | not specified | Likely benign (May 20, 2024) | ||
11-34658843-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
11-34658906-G-A | not specified | Uncertain significance (Oct 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EHF | protein_coding | protein_coding | ENST00000531794 | 9 | 39965 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.705 | 0.295 | 125681 | 0 | 8 | 125689 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.04 | 143 | 183 | 0.783 | 0.00000982 | 2148 |
Missense in Polyphen | 67 | 93.079 | 0.71982 | 1111 | ||
Synonymous | -0.00234 | 70 | 70.0 | 1.00 | 0.00000421 | 552 |
Loss of Function | 3.50 | 4 | 21.5 | 0.186 | 0.00000119 | 228 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000442 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional activator that may play a role in regulating epithelial cell differentiation and proliferation. May act as a repressor for a specific subset of ETS/AP-1-responsive genes and as a modulator of the nuclear response to mitogen- activated protein kinase signaling cascades. Binds to DNA sequences containing the consensus nucleotide core sequence GGAA. Involved in regulation of TNFRSF10B/DR5 expression through Ets- binding sequences on the TNFRSF10B/DR5 promoter. May contribute to development and carcinogenesis by acting as a tumor suppressor gene or anti-oncogene. {ECO:0000269|PubMed:10527851, ECO:0000269|PubMed:10644770, ECO:0000269|PubMed:11259407, ECO:0000269|PubMed:12444029, ECO:0000269|PubMed:17027647}.;
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- 0.477
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 32.94
Haploinsufficiency Scores
- pHI
- 0.491
- hipred
- Y
- hipred_score
- 0.654
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.533
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ehf
- Phenotype
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;multicellular organism development;cell population proliferation;cell differentiation;epithelial cell differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;epithelial cell proliferation
- Cellular component
- nucleus;nucleoplasm;Golgi apparatus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity